Table 1.
Comorbidity of Cardiovascular Diseases in Psoriasis.
| References | Subjects | Brief description |
|---|---|---|
| Ref.41 | Meta-analysis of 14 cohorts | Risk ratio relative to general population |
| Cardiovascular disease mortality; 1.37 (95% CI 1.17-1.60) | ||
| Myocardial infarction; 3.04 (95% CI 0.65-14.35) | ||
| Stroke; 1.59 (95% CI 1.34-1.89) | ||
| Ref.42 | German cross-sectional study (n=4,185) | Adjusted odds ratio |
| German Health Insurance beneficiaries (n=1,811,098) | Myocardial infarction; 2.26 (95% CI 1.03-4.96) | |
| Ref.43 | Control patients (n=556,995) | Adjusted relative risk in a 30-year old patient |
| Mild psoriasis (n=127,139) | Myocardial infarction in mild psoriasis; 1.29 (95% CI 1.14-1.46) | |
| Severe psoriasis (n=3,837) | Myocardial infarction in severe psoriasis; 3.10 (95% CI 1.98-4.86) | |
| Ref.44 | Control patients (n=14,330) | Adjusted relative risk in a 40-year old patient |
| Severe psoriasis (n=3,603) | Cardiovascular mortality in severe psoriasis; 2.69 (95% CI 1.45-4.99) | |
| Ref.46 | Prospective study for 5.2 years follow-up | Fully adjusted hazard ratio |
| Control patients (n=208,187) | Cardiovascular events; 1.02 (95% CI 0.95-1.08) | |
| Psoriasis (n=48,523) | ||
| Ref.47 | Hospital and clinic patients (n=113,065) | Adjusted odds ratio |
| Coronary heart disease; 1.27 (95% CI 1.01-1.58) | ||
| Hypertension; 7.78 (95% CI 7.25-8.36) | ||
| Ref.61 | Control patients (n=24,285) | Adjusted odds ratio |
| Psoriasis (n=12,502) | Hypertension; 1.37 (95% CI 1.29-1.46) |